Dhingra, Mamta Sachdeva, Dhingra, Sameer, Kumria, Rachna et al. · Pharmacological reports : PR · 2014 · DOI
This study tested whether a new compound derived from gallic acid (a plant antioxidant) could help reverse the harmful effects of chronic stress in mice. Researchers stressed mice by making them swim daily for 15 days, then treated them with the compound and measured changes in anxiety, memory, and harmful molecules in the brain. The treated mice showed improvements in movement, reduced anxiety, better memory, and lower levels of inflammation compared to untreated stressed mice.
ME/CFS patients show elevated oxidative stress and inflammatory markers similar to those measured in this study, making antioxidant and anti-inflammatory approaches theoretically relevant. Identifying compounds that reverse stress-induced behavioral and biochemical changes could inform development of new therapeutic strategies targeting the oxidative stress-inflammation cycle implicated in ME/CFS pathology.
This study does not demonstrate that trimethylgallic acid esters would be effective in humans with ME/CFS; findings from mouse stress models do not automatically translate to clinical efficacy. The study does not establish whether the compound addresses the root causes of ME/CFS or whether similar doses and routes of administration would be safe and effective in patients. Correlation between stress-induced markers and disease improvement does not prove causation in the context of complex, multifactorial conditions like ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →